David McManus, MD, ScM, is an esteemed clinical and research cardiologist and cardiac electrophysiologist who serves as the Richard M. Haidack Professor and Chair of the Department of Medicine at the University of Massachusetts Chan Medical School (UMass Chan). Known for his pioneering work in cardiac electrophysiology and digital medicine, Dr. McManus leads transformative research focused on integrating technology with cardiovascular care, notably as the founding director of the NIH-funded Center for Advancing Point-of-Care Technologies (CAPCaT) and as a contributor to the NIH’s Rapid Acceleration of Diagnostics (RADx) initiative during the COVID-19 pandemic.
Dr. McManus has led numerous high-impact clinical trials, including SAGE-AF, VITAL-AF, and PULSEWATCH, advancing the field of point-of-care diagnostics. He holds leadership roles with national cardiology and health organizations, including the Heart Rhythm Society, American College of Cardiology, and American Heart Association, where he currently serves as President-Elect of the Board of Directors.
As the founding director of the UMass Program in Digital Medicine, Dr. McManus launched the Health AI Assurance Laboratory, a state-funded initiative in partnership with MITRE’s AI Assurance and Discovery Lab, to rigorously evaluate AI applications in healthcare. Through this and other programs, he is also dedicated to training the next generation of health AI professionals, establishing the NIH-funded CODER Training Program, and overseeing internships and innovation training for young STEM learners. He has published over 300 manuscripts, secured over $140 million in NIH funding, and is the founding Editor-in-Chief of Digital Cardiovascular Health Journal.